RadNet PE Ratio 2012-2026 | RDNT
Current and historical p/e ratio for RadNet (RDNT) from 2012 to 2026. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. RadNet PE ratio as of May 14, 2026 is 142.13.
| RadNet PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2026-05-15 | 52.39 | 0.00 | |
| 2026-03-31 | 55.89 | $-0.17 | 0.00 |
| 2025-12-31 | 71.35 | $-0.25 | 0.00 |
| 2025-09-30 | 76.21 | $-0.17 | 0.00 |
| 2025-06-30 | 56.91 | $-0.20 | 0.00 |
| 2025-03-31 | 49.72 | $-0.43 | 0.00 |
| 2024-12-31 | 69.84 | $0.04 | 1746.00 |
| 2024-09-30 | 69.39 | 0 | 0.00 |
| 2024-06-30 | 58.92 | $0.21 | 280.57 |
| 2024-03-31 | 48.66 | $0.37 | 131.51 |
| 2023-12-31 | 34.77 | $0.05 | 695.40 |
| 2023-09-30 | 28.19 | $-0.01 | 0.00 |
| 2023-06-30 | 32.62 | $-0.25 | 0.00 |
| 2023-03-31 | 25.03 | $-0.24 | 0.00 |
| 2022-12-31 | 18.83 | $0.17 | 110.76 |
| 2022-09-30 | 20.35 | $0.12 | 169.58 |
| 2022-06-30 | 17.28 | $0.41 | 42.15 |
| 2022-03-31 | 22.37 | $0.33 | 67.79 |
| 2021-12-31 | 30.11 | $0.46 | 65.46 |
| 2021-09-30 | 29.31 | $0.66 | 44.41 |
| 2021-06-30 | 33.69 | $0.48 | 70.19 |
| 2021-03-31 | 21.75 | $0.22 | 98.86 |
| 2020-12-31 | 19.57 | $-0.29 | 0.00 |
| 2020-09-30 | 15.35 | $-0.21 | 0.00 |
| 2020-06-30 | 15.87 | $-0.27 | 0.00 |
| 2020-03-31 | 10.51 | $0.04 | 262.75 |
| 2019-12-31 | 20.30 | $0.29 | 70.00 |
| 2019-09-30 | 14.36 | $0.68 | 21.12 |
| 2019-06-30 | 13.79 | $0.72 | 19.15 |
| 2019-03-31 | 12.39 | $0.73 | 16.97 |
| 2018-12-31 | 10.17 | $0.66 | 15.41 |
| 2018-09-30 | 15.05 | $-0.09 | 0.00 |
| 2018-06-30 | 15.00 | $-0.12 | 0.00 |
| 2018-03-31 | 14.40 | $-0.12 | 0.00 |
| 2017-12-31 | 10.10 | $0.00 | 0.00 |
| 2017-09-30 | 11.55 | $0.21 | 55.00 |
| 2017-06-30 | 7.75 | $0.18 | 43.06 |
| 2017-03-31 | 5.90 | $0.15 | 39.33 |
| 2016-12-31 | 6.45 | $0.15 | 43.00 |
| 2016-09-30 | 7.40 | $0.11 | 67.27 |
| 2016-06-30 | 5.34 | $0.25 | 21.36 |
| 2016-03-31 | 4.83 | $0.25 | 19.32 |
| 2015-12-31 | 6.18 | $0.17 | 36.35 |
| 2015-09-30 | 5.55 | $0.27 | 20.56 |
| 2015-06-30 | 6.69 | $0.19 | 35.21 |
| 2015-03-31 | 8.40 | $0.23 | 36.52 |
| 2014-12-31 | 8.54 | $0.03 | 284.67 |
| 2014-09-30 | 6.62 | $-0.07 | 0.00 |
| 2014-06-30 | 6.63 | $-0.18 | 0.00 |
| 2014-03-31 | 2.84 | $-0.23 | 0.00 |
| 2013-12-31 | 1.67 | $0.05 | 33.40 |
| 2013-09-30 | 2.41 | $1.35 | 1.79 |
| 2013-06-30 | 2.65 | $1.49 | 1.78 |
| 2013-03-31 | 2.80 | $1.49 | 1.88 |
| 2012-12-31 | 2.53 | $1.52 | 1.66 |
| 2012-09-30 | 2.78 | $0.32 | 8.69 |
| 2012-06-30 | 2.66 | $0.19 | 14.00 |
| 2012-03-31 | 3.18 | $0.21 | 15.14 |
| 2011-12-31 | 2.13 | $0.19 | 11.21 |
| 2011-09-30 | 2.44 | $0.16 | 15.25 |
| 2011-06-30 | 4.40 | $0.15 | 29.33 |
| 2011-03-31 | 3.50 | $-0.26 | 0.00 |
| 2010-12-31 | 2.82 | $-0.35 | 0.00 |
| 2010-09-30 | 2.40 | $-0.42 | 0.00 |
| 2010-06-30 | 2.37 | $-0.46 | 0.00 |
| 2010-03-31 | 3.18 | $-0.15 | 0.00 |
| 2009-12-31 | 2.04 | $-0.06 | 0.00 |
| 2009-09-30 | 2.59 | $-0.23 | 0.00 |
| 2009-06-30 | 2.25 | $-0.18 | 0.00 |
| 2009-03-31 | 1.24 | $-0.23 | 0.00 |
| 2008-12-31 | 3.35 | $-0.36 | 0.00 |
| 2008-09-30 | 4.01 | $-0.54 | 0.00 |
| 2008-06-30 | 6.20 | $-0.60 | 0.00 |
| 2008-03-31 | 7.04 | $-0.51 | 0.00 |
| 2007-12-31 | 10.15 | $-0.52 | 0.00 |
| 2007-09-30 | 8.90 | $-0.25 | 0.00 |
| 2007-06-30 | 9.53 | $-0.23 | 0.00 |
| 2007-03-31 | 5.71 | $-0.38 | 0.00 |
| 2006-12-31 | 4.62 | $-0.28 | 0.00 |
| 2006-10-31 | 5.14 | $-0.25 | 0.00 |
| 2006-09-30 | 5.44 | $-0.35 | 0.00 |
| 2006-07-31 | 3.40 | $-0.37 | 0.00 |
| 2006-06-30 | 3.50 | $-0.33 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $4.302B | $2.040B |
| RadNet, Inc., is a national market leader providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers. RadNet offers to its patients and referring physicians the full spectrum of diagnostic imaging exams, including PET/CT, MRI, CT, Nuclear Medicine, Mammography, Ultrasound and X-ray, as well as numerous other procedures. RadNet utilizes best of breed technology to appropriately serve the medical communities in which it operates. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $29.514B | 13.37 |
| Quest Diagnostics (DGX) | United States | $21.197B | 19.44 |
| Elanco Animal Health (ELAN) | United States | $11.500B | 24.35 |
| Encompass Health (EHC) | United States | $10.662B | 19.64 |
| DaVita (DVA) | United States | $10.023B | 13.82 |
| Chemed (CHE) | United States | $5.639B | 19.57 |
| Option Care Health (OPCH) | United States | $4.553B | 18.71 |
| LifeStance Health (LFST) | United States | $2.495B | 320.00 |
| Addus HomeCare (ADUS) | United States | $1.719B | 16.61 |
| Astrana Health (ASTH) | United States | $1.536B | 31.40 |
| Aveanna Healthcare Holdings (AVAH) | United States | $1.353B | 12.20 |
| U.S Physical Therapy (USPH) | United States | $1.157B | 29.19 |
| Pennant (PNTG) | United States | $1.072B | 31.31 |
| Daxor (DXR) | United States | $0.048B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.032B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |